OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Overview Fund Activity
Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

29 hedge funds and large institutions have $7.26M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
7
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wells Fargo
Wells Fargo
California
$2.03M
2
Renaissance Technologies
Renaissance Technologies
New York
$1.9M
3
Citadel Advisors
Citadel Advisors
Florida
$102K
4
PCM
Perritt Capital Management
Illinois
$257K
5
NFSG
Newbridge Financial Services Group
Florida
$16K

Top Sellers

1
GCP
GSA Capital Partners
United Kingdom
$0
2
Squarepoint
Squarepoint
New York
$0
3
Northern Trust
Northern Trust
Illinois
$415K
4
Vanguard Group
Vanguard Group
Pennsylvania
$794K
5
Morgan Stanley
Morgan Stanley
New York
$68K
Name Holding Trade Value Shares
Change 		Shares
Change %
ASN
26
Advisory Services Network
Georgia
$3K +$3K +350 New
Fidelity Investments
27
Fidelity Investments
Massachusetts
$2K – – –
ARMC
28
American Research & Management Company
Massachusetts
$2K – – –
Federated Hermes
29
Federated Hermes
Pennsylvania
$2K +$368 +56 +23%
GCP
30
GSA Capital Partners
United Kingdom
– -$203K -27,110 Closed
Squarepoint
31
Squarepoint
New York
– -$90K -12,087 Closed
PCM
32
Prelude Capital Management
New York
– -$10K -1,400 Closed
1
2